--- title: 'Director, IT Service Delivery and Enterprise Applications at Relay Therapeutics' canonical: 'https://feeny.ai/job/director-it-service-delivery-and-enterprise-applications-relay-therapeutics-f9hzr66r1fke' type: 'job' last_seen: '2026-10-13' --- # Director, IT Service Delivery and Enterprise Applications at Relay Therapeutics - **Company:** Relay Therapeutics - **Location:** Cambridge, MA - **Posted:** 2026-10-05 - **Last confirmed live:** 2026-10-13 - **Apply:** https://job-boards.greenhouse.io/relaytherapeutics/jobs/6215684004 ## Job description Position Summary As the Director, IT Service Delivery and Enterprise Applications, you will own day-to-day service delivery for Relay Therapeutics’ IT support operations as well as lead our technology engagements with across G&A (including Finance, Accounting, People (HR), Legal, Corporate Communications, Investor Relations, Operations and Facilities). This is a hands-on leadership role reporting to the Head of IT that will serve as the face of service delivery, ensure a positive employee IT experience, stay close to the technical details of support operations, and partner with IT Operations, vendors and internal business partners to deliver solutions across the G&A teams. ## Key Responsibilities IT Service Delivery - Serve as the primary point of contact for all IT service delivery matters, escalations, service delivery performance, user satisfaction, and stakeholder communications. - Lead the on-site support team contractors and coordinate closely with any remote service desk and external partners - Ensuring successful day-to-day operation of Relay’s Microsoft 365 environment and connected technologies - Work closely with IT Operations to ensure high-quality support across deskside support, Microsoft 365, endpoint and asset management, Audio/Visual technology, lab systems, and related IT services - Own the execution and continual improvement of inventory and asset management processes, organization-wide IT communications/training, lab system/machine backups - Prepare and deliver operational reporting, incident analysis, root cause analysis for major or recurring issues, project status updates, associated risks, and estimated completion timelines. - Partner with IT Operations on projects and initiatives, including Microsoft 365 and AI technologies, to ensure thorough operational readiness for enterprise applications. - Partner with the support service provider to track and review service trends, performance metrics, and opportunities for standardization, operational efficiency, automation, and cost savings. Enterprise Applications - Manage the design and execution of processes supporting SOX compliance (including evidence collection), resource onboarding/offboarding, and eDiscovery - Work with Finance as the IT primary point of contact for SOX related inquiries, ensuring processes related to Help Desk requests and activities related to account management for onboarding, offboarding, and access requests are consistently documented and executed. - Work with remote support and internal business teams to ensure the successful continued operation and enhancement of the Boomi Enterprise Platform to support Finance, the People team, and Legal processes. - Work with Legal as the IT primary point of contact for all eDiscovery related efforts, including email and content data from the Microsoft environment and related email/file backups. - Partner with the G&A business functions in best leveraging Enterprise IT technologies including Microsoft (collaboration, Power Platform) and AI tools. Required Qualifications - Associate or Bachelor's degree in Computer Science, Information Technology, System Administration, or a closely related field, or equivalent experience required - 10+ years of experience in IT leadership spanning IT service delivery and/or supporting G&A organizations, service desk management, or end-user support leadership. - Experience managing on-site and remote support teams in an end user-facing environment. - Experience leading efforts related to new-to-you systems and business processes - Experience working in a regulated, compliance-driven, or security-conscious environment - Strong understanding of ITIL, IT service management practices, incident management, service request workflows, escalation management, and SLA-driven operations. - Ability to manage multiple priorities, coordinate resources, and lead cross-functional initiatives. - Strong written and verbal communication skills, with the ability to engage effectively with technical teams, business stakeholders, and vendors. - Experience with end-user support environments that include Microsoft 365, Windows, macOS, lab systems, onboarding/offboarding, and asset management. - Excellent organizational and documentation skills with a continuous improvement mindset. - Strong background in change management, with demonstrated success in managing complex organizational changes - Expertise in IT financial management, including budgeting, forecasting, and cost optimization techniques, SOX reporting Success in This Role Success in this role is measured by reliable service delivery, strong stakeholder satisfaction, timely resolution and escalation management, clear and actionable reporting, improved service trends and efficiency, and effective coordination of people, processes, and vendors to support Relay Therapeutics’ business and end-user needs. Estimated Salary Range: [$161,000 - $230,000]. The range provided above is based on what we believe to be a reasonable estimate for this job at the time of posting. Actual base salary will depend on a number of factors, including but not limited to, a candidate’s education, experience, skills and location. #BP1 ## About Relay Therapeutics Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. We have built a world-class team of leading experts from each of these disciplines, and they are driven by a deep collaboration at every step of our drug discovery process. Our team is equal parts fearless and relentless, with a shared passion for working collaboratively in intellectually stimulating environments. If you’re excited by the challenge of putting protein motion at the heart of drug discovery and passionate about making a difference in the lives of patients, join us! ## About Relay Therapeutics ## Company Overview - **One-liner**: Relay Therapeutics is a clinical-stage precision medicines company that uses its Dynamo® platform to visualize protein motion and drug previously intractable targets, with an initial focus on precision oncology and genetic disease. - **Entity Type**: Public (NASDAQ: RLAY) - **Headquarters**: Cambridge, Massachusetts, United States - **Founded**: 2016 - **Founders**: Not publicly listed as individual founders; the company was launched by Third Rock Ventures. ## Core Business - **Primary industry/industries**: Biotechnology, Precision Oncology, Genetic Disease Therapeutics - **Target customers**: Patients with specific cancer mutations (e.g., PI3Kα, FGFR2, NRAS) and rare genetic diseases (e.g., Fabry disease, PROS); partners are healthcare providers, clinical trial sites, and regulatory bodies. - **Mission or purpose statement**: "We aim to drug the undruggable." The company is laser-focused on bringing life-changing medicines to patients by visualizing protein motion to discover new therapeutics. ## Products & Services - **Dynamo® Platform**: A proprietary drug discovery platform that integrates long-timescale molecular dynamics (MD) simulations, cryo-electron microscopy (cryo-EM), and other biophysical techniques to visualize protein motion and identify novel drug binding sites. This is the core technology enabling all pipeline programs. - **Zovegalisib (RLY-2608)**: A clinical-stage, allosteric, pan-mutant and isoform-selective PI3Kα inhibitor. It is designed to overcome the toxicity of orthosteric inhibitors by sparing wild-type PI3Kα. Currently in a Phase 3 trial (ReDiscover-2) for HR+/HER2- PI3Kα-mutated advanced breast cancer and a Phase 1/2 trial for PROS and vascular anomalies. - **Lirafugratinib (RLY-4008)**: A selective FGFR2 inhibitor. In December 2024, global development and commercialization rights were out-licensed to Elevar Therapeutics. - **RLY-8161**: A first-in-class, NRAS-selective inhibitor designed to address the liabilities of pan-RAS inhibitors. Currently in a Phase 1/2 trial for NRAS-mutant melanoma and other solid tumors. - **Fabry Disease Program**: An investigational non-inhibitory chaperone designed to stabilize the αGal enzyme without inhibiting its activity, potentially offering a chronic treatment option for Fabry disease. Currently in IND-enabling studies. ## Market Standing - **Valuation/Market Cap**: $909.1 million (as of mid-2026) [linkedin.com](https://www.linkedin.com/company/relay-therapeutics-inc.) - **Key Metric**: Annual Revenue of $15.4 million (pre-commercial, primarily from collaboration/grants) [linkedin.com](https://www.linkedin.com/company/relay-therapeutics-inc.) - **Total Funding**: $1.8 billion (including IPO and follow-on offerings) [linkedin.com](https://www.linkedin.com/company/relay-therapeutics-inc.) - **Notable Investors/Partners**: Third Rock Ventures (founding investor), Nextech Invest, Elevar Therapeutics (out-license partner for lirafugratinib). - **Growth Signals**: Initiation of the Phase 3 ReDiscover-2 trial for zovegalisib in mid-2025; out-license of lirafugratinib to Elevar Therapeutics in December 2024; advancement of RLY-8161 into Phase 1/2 for NRAS-mutant cancers; expansion of the pipeline into genetic diseases (Fabry). ## Competitive Advantages - **Dynamo® Platform Moat**: The company's core differentiator is its ability to use long-timescale molecular dynamics simulations to visualize protein motion. This allows them to drug targets (like allosteric sites on PI3Kα and NRAS) that are "undruggable" with traditional static-structure approaches. - **Selectivity & Tolerability**: Their lead asset, zovegalisib, is designed to be a pan-mutant, isoform-selective PI3Kα inhibitor. This selectivity for mutant over wild-type PI3Kα is a key advantage over first-generation orthosteric inhibitors, potentially offering better efficacy and chronic tolerability. - **First-in-Class Potential**: RLY-8161 is described as the first NRAS-selective inhibitor, addressing a major unmet need in NRAS-mutant cancers by sparing KRAS and HRAS, which are responsible for the toxicity of pan-RAS inhibitors. ## Strategic Focus - **Advancing Late-Stage Pipeline**: The primary focus is on executing the Phase 3 ReDiscover-2 trial for zovegalisib in breast cancer and expanding its potential in vascular anomalies (PROS). - **Expanding Pipeline**: Advancing RLY-8161 (NRAS) through Phase 1/2 and moving the Fabry disease program toward clinical trials. - **Platform Validation**: Continuing to use the Dynamo® platform to discover new drug candidates for previously intractable targets, thereby validating the platform's broader potential beyond current pipeline assets. ## Why Work Here - **Culture**: The company describes its culture as "highly integrated, collaborative and entrepreneurial." Employees emphasize that the team is "equal parts bright and bold" and that the work is a "personal mission" driven by a desire to help patients. The culture values candor, quirkiness, and sweating the details. [relaytx.com](https://relaytx.com/careers/) - **Work Environment**: Based in Cambridge, MA (Kendall Square area). The company is on-site/hybrid, typical for a biotech R&D environment. The team is described as "world-class" and "highly integrated." - **Notable Perks**: The company offers competitive benefits and perks, investing in employee well-being, financial health, and family support. [relaytx.com](https://relaytx.com/careers/) - **Engineering & Science Culture**: The company emphasizes a highly collaborative environment where computational scientists (cheminformatics, computational architecture) work side-by-side with experimental biologists, chemists, and structural biologists. The focus on "protein motion" creates a unique intellectual challenge. ## Sources 1. [relaytx.com](https://relaytx.com/) 2. [relaytx.com](https://relaytx.com/pipeline/) 3. [relaytx.com](https://relaytx.com/careers/) 4. [linkedin.com](https://www.linkedin.com/company/relay-therapeutics-inc.) 5. [greenhouse.io](http://job-boards.greenhouse.io/relaytherapeutics) ## Other roles at Relay Therapeutics - [Associate Director, Drug Substance](https://feeny.ai/job/associate-director-drug-substance-relay-therapeutics-cambridge-wg1mp3ks5hhe) — Cambridge, MA - [Medical Director](https://feeny.ai/job/medical-director-relay-therapeutics-cambridge-dqfwq8bjw6gh) — Cambridge, MA - [Associate Director, Biostatistics](https://feeny.ai/job/associate-director-biostatistics-relay-therapeutics-cambridge-ykyy55zptr84) — Cambridge, MA - [Associate Director, Regulatory Project Management](https://feeny.ai/job/associate-director-regulatory-project-management-relay-therapeutics-cambridge-jhp36tb9dz27) — Cambridge, MA - [Director/Senior Director, Clinical Pharmacology](https://feeny.ai/job/director-senior-director-clinical-pharmacology-relay-therapeutics-cambridge-qg6wd9az23g8) — Cambridge, MA - [Senior Manager, Clinical Data Management](https://feeny.ai/job/senior-manager-clinical-data-management-relay-therapeutics-cambridge-yf5gq3qx2xbh) — Cambridge, MA - [Medical Director/Senior Medical Director, Patient Safety & Risk Management](https://feeny.ai/job/medical-director-senior-medical-director-patient-safety-risk-management-relay-kq6nb9077wvg) — Cambridge, MA - [Associate Director/Director, CMC Regulatory](https://feeny.ai/job/associate-director-director-cmc-regulatory-relay-therapeutics-cambridge-fxx1zz50mb8r) — Cambridge, MA - [Medical Science Liaison - Southeast](https://feeny.ai/job/medical-science-liaison-southeast-relay-therapeutics-southeast-d8fmt3fthtgp) — Southeast - [Senior Manager, Clinical Business Operations](https://feeny.ai/job/senior-manager-clinical-business-operations-relay-therapeutics-cambridge-9c91kbpgewjr) — Cambridge, MA